You searched for "Wales"
How to be ‘appy’ on call: a brief guide to mobile phone applications for the on-call ophthalmologist
One of the unexpected outcomes of the COVID-19 pandemic has been an increased reliance and integration of computer technology within hospital medicine. The need for stricter infection control policies during and after lockdown has seen a boom in technology utilisation....Blind gaming group levels up at five years
A community of gamers with sight loss from across Scotland and Northern Ireland says its network is thriving as it marks its fifth anniversary. Formed during the pandemic lockdown in November 2020, as part of RNIB’s community work, the group...New SpaMedica site opens in Bexhill-on-Sea
SpaMedica, which specialises in NHS cataract surgery and YAG capsulotomy, will help to significantly reduce waiting times for East Sussex patients.CALA Homes donates white boards to help pupils at Royal Blind School
Homebuilder Cala Homes (East) has donated £3,130 to Sight Scotland for the purchase of two white boards to aid teaching at the Royal Blind School in Edinburgh.
Good News from Switzerland: A History of Retinal Reattachment Surgery
In one concise volume the reader learns of the recent rapid evolution in vitreoretinal (VR) surgery. The pioneering innovators were often remarkable personalities and this book helps to bring them to life. Prior to 1929 victims of retinal detachment were...
Microbial keratitis in corneal grafts
The authors report a retrospective case series of 59 episodes of microbial keratitis identified in 41 eyes of 41 patients (39 penetrating keratoplasty (PKPs) and two deep anterior lamellar keratoplasty (DALKs)), from a total of 759 consecutive corneal grafts identified...Corporate M&A pace gathers momentum
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
